Revolutionising cancer treatment one Array at a time

Blog - Pharmacogenetics, or the study of how people respond differently to medicines due to their genetics, is making a splash lately thanks to companies like Minneapolis, MN-based OneOme, which co-developed its RightMed test with Mayo Clinic

11 July 2018
LGC Genomics partners with Diagenode to expand NGS offering

News - Distribution agreement to supply range of state-of-the-art sonication systems for DNA fragmentation

16 November 2017
Innovate UK Awards Grant to MiNA Therapeutics and LGC LINK

News - Funding to develop liver targeted gene activation therapies

02 November 2017
National Measurement Laboratory team awarded £2.25m ISCF funding

News - Money will support the manufacture of future medicines through better measurement

08 January 2018
Customer Data: Use of Seraseq ctDNA Reference Samples to Validate Detection of Low Frequency Variants in a cfDNA-based NGS Lung Cancer Panel

Blog - Researchers at the New York Presbyterian Hospital (NYPH) and Weill Cornell Medical Center (WCMC) presented a poster on the validation of an Oncomine™ cell-free DNA Lung Assay using ctDNA NGS standards developed by SeraCare

22 February 2019
Highlights from SeraCare's AACR 2019 meeting experience

Blog - The team at SeraCare have been experiencing the sights and sounds of the annual AACR meeting this week in Atlanta, and they are exciting about what they're learning! Catherine Huang, Director of Product Development at SeraCare, shared her top highlights from Atlanta this week

05 April 2019
Precision Medicine and Clinical Labs: AACR Dinner Seminar Recap

Blog - SeraCare recently hosted a dinner seminar to discuss the very topic of how clinical labs with liquid biopsy assays can better support the development of clinical validation of liquid biopsies and then clinical utility in patient care.

23 April 2019
LGC, Biosearch Technologies testing workflow underpins expansion of COVID-19 testing in New York

News - Nexar workflow continues to enable simple, scalable, and cost-effective testing 

29 October 2021
LGC Clinical Diagnostics extend collaboration with Stanford Medicine supporting global genetic and metabolomic diagnostic testing

News - The exclusive partnership will also be extended to include the analysis of phenotypic-genotypic correlations and metabolic profiling of some common maternal/ fetal cardiac defects known to be related to monogenic disorders.

02 August 2022